CFTR and cystic fibrosis: The majority of cystic fibrosis (CF) in patients is caused by abnormal cystic fibrosis transmembrane conductance regulator (CFTR) folding, thus, understanding of the CFTR protein quality control mechanism requires the identification of new CF therapeutic target molecules which can then contribute to the development of CFTR modulator enhancers based on new molecular mechanisms.